The Congress should direct the Secretary to eliminate the end-stage renal disease prospective payment system’s transitional drug add-on payment adjustment for new drugs in an existing end-stage renal disease functional category.
Improving Medicare’s end-stage renal disease prospective payment system (1)
June 15, 2020